Welcome to our dedicated page for abrdn World Healthcare news (Ticker: THW), a resource for investors and traders seeking the latest updates and insights on abrdn World Healthcare stock.
abrdn World Healthcare Fund (THW) provides investors with focused exposure to global healthcare markets through strategic investments in pharmaceuticals, biotechnology, and medical technology. This news hub offers essential updates on the fund's portfolio activity, distribution policies, and market positioning.
Access real-time announcements including earnings reports, strategic acquisitions, and regulatory developments. Our curated collection ensures you stay informed about capital allocation decisions, sector-specific trends, and management commentary relevant to this closed-end healthcare fund.
Key updates cover portfolio rebalancing across therapeutic areas, income distribution details, and analysis of healthcare market dynamics. Bookmark this page for centralized access to THW's operational developments and industry insights that matter to long-term investors.
On August 10, 2022, Tekla World Healthcare Fund (NYSE: THW) announced a monthly cash distribution of $0.1167 per share. The record date for this distribution is August 22, 2022, with a payable date of August 31, 2022. The shares will trade ex-distribution on August 19, 2022. Only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan will have distributions automatically reinvested. Tekla Capital Management LLC manages the Fund, which focuses on investments in the healthcare sector.
On July 11, 2022, Tekla World Healthcare Fund (NYSE: THW) announced a monthly cash distribution of $0.1167 per share. The record date for this distribution is set for July 21, 2022, with the payable date on July 29, 2022. The shares will trade ex-distribution on July 20, 2022. Investors participating in the Fund's Dividend Reinvestment and Stock Purchase Plan will have distributions automatically reinvested. The Fund, managed by Tekla Capital Management LLC, focuses on healthcare investments.
On June 10, 2022, Tekla World Healthcare Fund (NYSE:THW) announced a monthly cash distribution of $0.1167 per share. The record date for this distribution is June 21, 2022, with payments made on June 30, 2022. The Fund will trade ex-distribution on June 17, 2022. Only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan will automatically reinvest cash distributions into shares.
Tekla World Healthcare Fund is a closed-end fund investing in healthcare companies, managed by Tekla Capital Management LLC from Boston.
On May 10, 2022, Tekla World Healthcare Fund (NYSE: THW) announced a monthly cash distribution of $0.1167 per share. The record date is May 20, 2022, with payments scheduled for May 31, 2022. Shares will trade ex-distribution on May 19, 2022. Only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan will have distributions automatically reinvested. The Fund, managed by Tekla Capital Management LLC, focuses on investments within the healthcare sector.
On April 11, 2022, Tekla World Healthcare Fund (NYSE:THW) announced a monthly cash distribution of $0.1167 per share. The record date for this distribution is April 21, 2022, and the payment will be made on April 29, 2022. The ex-distribution date is April 20, 2022. Only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan will have their distributions automatically reinvested. The Fund invests in healthcare companies and is advised by Tekla Capital Management LLC, located in Boston.
Tekla World Healthcare Fund announced the renewal of its share repurchase program, allowing it to buy back up to 12% of its outstanding shares until July 14, 2023. This decision follows a review aimed at enhancing shareholder value and reducing the discount between market price and net asset value per share. The buyback is expected to increase net asset value and improve share liquidity. Timing and amount of repurchases will be managed by Tekla Capital Management LLC, with no guarantee of price increases due to the program.
On March 10, 2022, Tekla World Healthcare Fund (NYSE:THW) announced a monthly cash distribution of $0.1167 per share. The record date for this distribution is set for March 21, 2022, with payments scheduled for March 31, 2022. The fund will trade ex-distribution on March 18, 2022. Only participants in the Dividend Reinvestment and Stock Purchase Plan will have distributions reinvested automatically. Tekla Capital Management LLC manages the fund, which focuses on healthcare investments.
On February 8, 2022, Tekla World Healthcare Fund (NYSE: THW) announced a monthly cash distribution of $0.1167 per share. The record date for this distribution is February 18, 2022, and payments will be made on February 28, 2022. The Fund will trade ex-distribution on February 17, 2022. Only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan will have their cash distributions automatically reinvested in shares.
Tekla Capital Management LLC, based in Boston, serves as the Investment Adviser for the Fund.
On January 10, 2022, Tekla World Healthcare Fund (NYSE: THW) announced a monthly cash distribution of $0.1167 per share, with a record date of January 20, 2022 and payable date on January 31, 2022. The fund will trade ex-distribution on January 19, 2022. Investors participating in the Dividend Reinvestment and Stock Purchase Plan will have their distributions automatically reinvested. The fund focuses on healthcare investments and is managed by Tekla Capital Management LLC, based in Boston.
On December 10, 2021, Tekla World Healthcare Fund (NYSE:THW) announced a monthly cash distribution of $0.1167 per share. The record date for this distribution is December 20, 2021, with a payable date set for December 31, 2021. Shares will trade ex-distribution on December 17, 2021. Only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan will have their cash distributions automatically reinvested. Tekla Capital Management LLC manages the Fund, which focuses on healthcare investments.